Usefulness of a novel and rapid assay system for fecal calprotectin in pediatric patients with inflammatory bowel diseases

Fecal Calprotectin More Accurately Reflects Endoscopic Activity of Ulcerative Colitis than the Lichtiger Index, C-reactive Protein, Platelets, Hemoglobin, and Blood Leukocytes

(2013) Alain M. Schoepfer et al.   INFLAMMATORY BOWEL DISEASES

Evaluation of Mucosal Healing of Ulcerative Colitis by a Quantitative Fecal Immunochemical Test

(2012) Asuka Nakarai et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Faecal chitinase 3-like-1: a novel biomarker of disease activity in paediatric inflammatory bowel disease

(2011) T. Aomatsu et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Analytical Comparison of Three Quantitative Immunochemical Fecal Occult Blood Tests for Colorectal Cancer Screening

(2011) L. Guittet et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Fecal Calprotectin Is a Useful Marker for Disease Activity in Pediatric Patients with Inflammatory Bowel Disease

(2011) Tomoki Aomatsu et al.   DIGESTIVE DISEASES AND SCIENCES

Safe and Effective Procedural Sedation for Gastrointestinal Endoscopy in Children

(2011) Elke J.A.H. van Beek et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Inflammation-associated S100 proteins: new mechanisms that regulate function

(2010) Jesse Goyette et al.   AMINO ACIDS

Pediatric modification of the Montreal classification for inflammatory bowel disease

(2010) Arie Levine et al.   INFLAMMATORY BOWEL DISEASES

Inflammatory bowel disease in children: epidemiological analysis of the nationwide IBD registry in Japan

(2010) Takashi Ishige et al.   JOURNAL OF GASTROENTEROLOGY

Fecal Calprotectin Correlates More Closely With the Simple Endoscopic Score for Crohn's Disease (SES-CD) than CRP, Blood Leukocytes and the CDAI

(2009) Alain M Schoepfer et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Monitoring disease activity by stool analyses: from occult blood to molecular markers of intestinal inflammation and damage

(2009) D Foell et al.   GUT

Ulcerative colitis

(2009) Alain M. Schoepfer et al.   INFLAMMATORY BOWEL DISEASES

Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohnʼs disease

(2009) Fabian Schnitzler et al.   INFLAMMATORY BOWEL DISEASES

Natural history of Crohnʼs disease

(2009) Bénédicte Pigneur et al.   INFLAMMATORY BOWEL DISEASES

Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn’s disease and histological findings

(2008) T. SIPPONEN et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Fecal calprotectin, lactoferrin, and endoscopic disease activity in monitoring anti-TNF-alpha therapy for Crohnʼs disease

(2008) Taina Sipponen et al.   INFLAMMATORY BOWEL DISEASES

Fecal calprotectin complements routine laboratory investigations in diagnosing childhood inflammatory bowel disease

(2008) Michael A. Quail et al.   INFLAMMATORY BOWEL DISEASES

Noninvasive Markers in the Assessment of Intestinal Inflammation in Inflammatory Bowel Diseases: Performance of Fecal Lactoferrin, Calprotectin, and PMN-Elastase, CRP, and Clinical Indices

(2007) Jost Langhorst et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Crohnʼs disease activity assessed by fecal calprotectin and lactoferrin: Correlation with Crohnʼs disease activity index and endoscopic findings

(2007) Taina Sipponen et al.   INFLAMMATORY BOWEL DISEASES